Volume 57, Issue 6, Pages (June 2000)

Slides:



Advertisements
Similar presentations
Volume 73, Issue 11, Pages (June 2008)
Advertisements

Volume 94, Issue 3, Pages (September 2018)
Gene expression of prostanoid forming enzymes along the rat nephron1
Volume 54, Issue 5, Pages (November 1998)
Volume 56, Issue 3, Pages (September 1999)
Syntaxin 3 and Munc-18-2 in epithelial cells during kidney development
Volume 64, Issue 1, Pages (July 2003)
Volume 61, Issue 4, Pages (April 2002)
Volume 60, Issue 6, Pages (December 2001)
Li Cui, Raymond K. Blanchard, Robert J. Cousins  Kidney International 
Volume 56, Issue 6, Pages (December 1999)
Kathryn J. Moore, Takashi Wada, Susannah D. Barbee, Vicki Rubin Kelley 
Volume 55, Issue 4, Pages (April 1999)
Volume 60, Issue 2, Pages (August 2001)
Carlton M. Bates, Heather Kegg, Christina Petrevski, Sandy Grady 
Volume 61, Issue 5, Pages (May 2002)
Actin cytoskeleton in ischemic acute renal failure
Volume 65, Issue 4, Pages (April 2004)
Localization of the prostacyclin receptor in human kidney
Expression of the sodium iodide symporter in human kidney
Kalu U.E. Ogbureke, Larry W. Fisher  Kidney International 
Volume 59, Issue 2, Pages (February 2001)
Volume 83, Issue 4, Pages (April 2013)
Volume 61, Issue 6, Pages (June 2002)
Volume 74, Issue 1, Pages (July 2008)
Volume 61, Issue 4, Pages (April 2002)
Differential expression of adenylyl cyclases in the rat nephron
Decreased renal ischemia–reperfusion injury by IL-16 inactivation
Volume 53, Issue 5, Pages (May 1998)
IL-18 is expressed in the intercalated cell of human kidney
Volume 60, Issue 5, Pages (November 2001)
Volume 57, Issue 6, Pages (June 2000)
Magnus Åbrink, Eric Larsson, Anders Gobl, Lars Hellman 
Volume 62, Issue 2, Pages (August 2002)
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Volume 54, Issue 2, Pages (August 1998)
Chun Shia Chang, R. Gary Kirk, Ping Lee  Kidney International 
Volume 60, Issue 6, Pages (December 2001)
Kenji Kasuno, Hajime Nakamura, Takahiko Ono, Eri Muso, Junji Yodoi 
Volume 53, Issue 5, Pages (May 1998)
Volume 73, Issue 12, Pages (June 2008)
Janet D. Klein, Robert B. Gunn, Brian R. Roberts, Jeff M. Sands 
Volume 63, Issue 4, Pages (April 2003)
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 56, Issue 2, Pages (August 1999)
Volume 61, Issue 6, Pages (June 2002)
Wei-Zhong Ying, Pei-Xuan Wang, Paul W. Sanders  Kidney International 
Volume 65, Issue 2, Pages (February 2004)
Volume 58, Issue 6, Pages (December 2000)
Volume 63, Issue 2, Pages (February 2003)
Volume 58, Issue 2, Pages (August 2000)
Volume 76, Issue 7, Pages (October 2009)
Calcitonin receptor isoforms expressed in the developing rat kidney
Distribution of postsynaptic density proteins in rat kidney: Relationship to neuronal nitric oxide synthase  Akihiro Tojo, David S. Bredt, Christopher.
Volume 68, Issue 2, Pages (August 2005)
Resistance of mTAL Na+-dependent transporters and collecting duct aquaporins to dehydration in 7-month-old rats  Hassane Amlal, Catherine Wilke  Kidney.
Volume 55, Issue 6, Pages (June 1999)
Volume 56, Issue 1, Pages (July 1999)
Babu J. Padanilam, Andrew J.P. Lewington, Marc R. Hammerman 
Immunolocalization of phospholipase C isoforms in rat kidney
Volume 55, Issue 3, Pages (March 1999)
Ubiquitous localization of leukotriene A4 hydrolase in the rat nephron
Volume 59, Issue 2, Pages (February 2001)
Volume 55, Issue 3, Pages (March 1999)
Volume 71, Issue 8, Pages (April 2007)
Volume 58, Issue 6, Pages (December 2000)
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Richard A. Zager, Ali Johnson, Sherry Hanson, Vivian Dela Rosa 
Kathryn J. Moore, Takashi Wada, Susannah D. Barbee, Vicki Rubin Kelley 
Transplantation of developing metanephroi into adult rats
Presentation transcript:

Volume 57, Issue 6, Pages 2445-2456 (June 2000) Redistribution of cytoplasmic VEGF to the basolateral aspect of renal tubular cells in ischemia-reperfusion injury  John Kanellis, Stuart J. Mudge, Scott Fraser, Marina Katerelos, David A. Power  Kidney International  Volume 57, Issue 6, Pages 2445-2456 (June 2000) DOI: 10.1046/j.1523-1755.2000.00103.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Immunohistochemical staining for vascular endothelial growth factor (VEGF) in ischemia-reperfused kidneys using a monoclonal antibody raised against human VEGF121 (VEGF Ab-5). Abbreviations indicate the following structures for all panels: D, distal convoluted tubule (DCT); P, proximal convoluted tubule (PCT); C, collecting duct; and S, peritubular space. (A and B) Normal kidney showing diffuse cytoplasmic staining for VEGF in tubules of the cortex (A) and medulla (B). PCT, DCT, macula densa, collecting ducts, and loop of Henle had similar staining. (C–E) Ischemic kidneys (no reperfusion) showing prominent globular structures with staining for VEGF (arrowheads) at the basolateral aspect of all tubules of the cortex (C and D) and outer medulla (E). Perinuclear globular structures positive for VEGF are also demonstrated (arrows; D). The peritubular spaces show expansion consistent with interstitial edema, as well as red cell accumulation and extravasation. (F and G) Ischemic kidneys reperfused for 20 minutes. There is less basolateral localization of staining for VEGF, with medullary collecting ducts showing prominent, but more diffuse cytoplasmic staining (F). Some cortical tubules continue to show variable staining for VEGF in globular structures localized to the basolateral aspect of cells (arrowheads; G). (H) Cortex of ischemic kidney reperfused for 80 minutes, showing prominent, diffuse staining for VEGF, with less localization to the basolateral area. Negative controls using an isotype-matched irrelevant monoclonal antibody in place of VEGF Ab-5 showed no staining (data not shown, but appearances were similar to Figure 2a). Control kidneys (contralateral nonischemic kidneys) showed VEGF staining similar to normal kidneys (data also not shown). All magnifications ×100 except for E ×150, D ×180, and G ×200. Kidney International 2000 57, 2445-2456DOI: (10.1046/j.1523-1755.2000.00103.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Immunohistochemical staining for VEGF in ischemia-reperfused kidneys using polyclonal VEGF-164 Ab. Abbreviations indicate the following structures for all panels: C, collecting duct; H, thin segment of Henle's loop. (A) Negative control using normal rabbit IgG in place of VEGF-164 Ab. (B) Medulla of normal kidney showing diffuse cytoplasmic staining for VEGF in collecting ducts and the loop of Henle. (C) Medulla of ischemic kidney (no reperfusion) showing prominent staining for VEGF at the basolateral aspect of collecting duct cells (arrowheads). (D) Medulla of ischemic kidney reperfused for 20 minutes, showing prominent staining for VEGF at the basolateral aspect of collecting duct cells (arrowheads). Magnifications: A and B, ×100; C and D, ×150. Kidney International 2000 57, 2445-2456DOI: (10.1046/j.1523-1755.2000.00103.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Western blots of cytoplasmic and membrane-enriched protein samples probed with VEGF-147 Ab. (A, top panel) Cytoplasmic fractions. (Lower panel) Membrane fractions. Normal kidney (lane 1), left ischemia-reperfused (LIR) kidneys (lanes 2 through 5), and contralateral right normal (RN) kidneys (lanes 6 through 9) are shown. LIR kidneys were subjected to 40 minutes of ischemia with variable reperfusion times (indicated in minutes). RN kidneys were harvested at the time of LIR kidney removal. Cytoplasmic blots demonstrated a single species (∼28 kD). Membrane blots demonstrated two species (∼28 and 31 kD). The blots shown are representative of four separate groups. (B) Densitometric analysis of cytoplasmic blots (means ± SD) showing a decrease in VEGF164 to 25% of normal after 40 minutes of ischemia, which persisted despite 20 minutes of reperfusion (LIR 0 and LIR 20; **P < 0.01). Levels returned toward normal after 40 minutes or more of reperfusion (LIR 40 and LIR 80). Levels in the RN kidneys were similar to normal. (C) Densitometric analysis of membrane blots (means ± SD) showing no significant alteration in VEGF164 and VEGF188 levels in LIR kidneys compared with normal. Kidney International 2000 57, 2445-2456DOI: (10.1046/j.1523-1755.2000.00103.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Northern blot of total RNA samples, ischemia reperfusion model. (A) Northern blot demonstrating VEGF mRNA (single species of approximately 3.7 kb) relative to GAPDH mRNA. Normal kidney (lane 1), contralateral normal kidneys (lanes 2 through 5), and ischemia-reperfused kidneys (lanes 6 through 9) are shown. The blot is representative of four separate groups. (B) Densitometric analysis of Northern blots from the four groups of rats (means ± SD). Mean VEGF mRNA levels in the LIR kidneys showed no significant change compared with normal and RN kidneys. Kidney International 2000 57, 2445-2456DOI: (10.1046/j.1523-1755.2000.00103.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 5 Laser scanning confocal fluorescence microscopy on NRK52-E subjected to re-oxygenation after hypoxia. In all panels, nucleii were counterstained with propidium iodine. Staining for VEGF (cytoplasmic) used VEGF Ab-5. (A) Negative control for VEGF Ab-5 using an irrelevant isotype matched monoclonal antibody. (B) Normal NRK52-E showing slight cytoplasmic staining for VEGF. (C and D) NRK52-E following 40 minutes of hypoxia (C), and with five minutes of re-oxygenation (D), showing an increase in staining for VEGF and prominent localization of VEGF at the periphery of the cells. (E) NRK52-E following 40 minutes of hypoxia and 20 minutes of re-oxygenation showing diffuse cytoplasmic staining for VEGF in most of the cells (cells at the top of E). Occasional cells showed persistent peripheral VEGF staining (cells at the bottom of E). (F) NRK52-E following 40 minutes of hypoxia and 40 minutes of re-oxygenation showing diffuse staining for VEGF in the cytoplasm of cells. Cells re-oxygenated for 80 minutes had a similar appearance to cells re-oxygenated for 40 minutes (data not shown). Magnifications: A, B, and E, ×600; C and D, ×900; F, ×800. Kidney International 2000 57, 2445-2456DOI: (10.1046/j.1523-1755.2000.00103.x) Copyright © 2000 International Society of Nephrology Terms and Conditions